Sodium phenylbutyrate
SIGMA/SML0309 - ≥98% (HPLC)
Synonym: 4-PBA; 4-Phenylbutyric acid; 4-phenylbutyrate; Buphenyl; Sodium 4-phenylbutyrate; TriButyrate
CAS Number: 1716-12-7
Empirical Formula (Hill Notation): C10H11NaO2
Molecular Weight: 186.18
MDL Number: MFCD00800247
Linear Formula: C10H11NaO2
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C10H12O2.Na/c11-10(12) |
| InChI key | VPZRWNZGLKXFOE-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | [Na+].[O-]C(=O)CCCc1ccccc |
| solubility | H2O: ≥5 mg/mL |
| storage temp. | room temp |
| Application: | Sodium phenylbutyrate has been used as an endoplasmic reticulum (ER) stress inhibitor to study the role of ER stress in the expression of betatrophin. |
| Biochem/physiol Actions: | Sodium phenylbutyrate is a histone deacetylase inhibitor. |
| Features and Benefits: | This compound is a featured product for Gene Regulation research. Click here to discover more featured Gene Regulation products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
| General description: | Sodium phenylbutyrate stimulates urinary nitrogen excretion. It is a prodrug, which undergoes β-oxidation to phenylacetate. Sodium phenylbutyrate is used to treat urea cycle disorder. It might be associated with menstrual dysfunction, amenorrhea and painful mucositis of the esophagus and stomach. |
| Packaging: | 100 mg in glass bottle |
| Hazard Codes | Xi |
| Risk Statements | 36 |
| Safety Statements | 26 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | room temp |
| UNSPSC | 12352200 |

